{"nct_id":"NCT01053936","title":"Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2010-01-31","start_date_type":"ACTUAL","primary_completion_date":"2010-12-31","primary_completion_date_type":"ACTUAL","completion_date":"2011-02-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BIIB"]}